These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

488 related items for PubMed ID: 12646262

  • 1. Loss of p53 induces M-phase retardation following G2 DNA damage checkpoint abrogation.
    Minemoto Y, Uchida S, Ohtsubo M, Shimura M, Sasagawa T, Hirata M, Nakagama H, Ishizaka Y, Yamashita K.
    Arch Biochem Biophys; 2003 Apr 01; 412(1):13-9. PubMed ID: 12646262
    [Abstract] [Full Text] [Related]

  • 2. Characterization of adriamycin-induced G2 arrest and its abrogation by caffeine in FL-amnion cells with or without p53.
    Minemoto Y, Gannon J, Masutani M, Nakagama H, Sasagawa T, Inoue M, Masamune Y, Yamashita K.
    Exp Cell Res; 2001 Jan 01; 262(1):37-48. PubMed ID: 11120603
    [Abstract] [Full Text] [Related]

  • 3. G2 delay induced by nitrogen mustard in human cells affects cyclin A/cdk2 and cyclin B1/cdc2-kinase complexes differently.
    O'Connor PM, Ferris DK, Pagano M, Draetta G, Pines J, Hunter T, Longo DL, Kohn KW.
    J Biol Chem; 1993 Apr 15; 268(11):8298-308. PubMed ID: 8463339
    [Abstract] [Full Text] [Related]

  • 4. The role of Cdc2 feedback loop control in the DNA damage checkpoint in mammalian cells.
    Poon RY, Chau MS, Yamashita K, Hunter T.
    Cancer Res; 1997 Nov 15; 57(22):5168-78. PubMed ID: 9371520
    [Abstract] [Full Text] [Related]

  • 5. F9 embryonal carcinoma cells fail to stop at G1/S boundary of the cell cycle after gamma-irradiation due to p21WAF1/CIP1 degradation.
    Malashicheva AB, Kislyakova TV, Aksenov ND, Osipov KA, Pospelov VA.
    Oncogene; 2000 Aug 10; 19(34):3858-65. PubMed ID: 10951579
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Delta MEKK3:ER* activation induces a p38 alpha/beta 2-dependent cell cycle arrest at the G2 checkpoint.
    Garner AP, Weston CR, Todd DE, Balmanno K, Cook SJ.
    Oncogene; 2002 Nov 21; 21(53):8089-104. PubMed ID: 12444545
    [Abstract] [Full Text] [Related]

  • 8. UCN-01: a potent abrogator of G2 checkpoint function in cancer cells with disrupted p53.
    Wang Q, Fan S, Eastman A, Worland PJ, Sausville EA, O'Connor PM.
    J Natl Cancer Inst; 1996 Jul 17; 88(14):956-65. PubMed ID: 8667426
    [Abstract] [Full Text] [Related]

  • 9. Regulation of the G2/M transition by p53.
    Taylor WR, Stark GR.
    Oncogene; 2001 Apr 05; 20(15):1803-15. PubMed ID: 11313928
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Changes in cyclins and cyclin-dependent kinases induced by DNA damaging agents in a human ovarian cancer cell line expressing mutated or wild-type P53.
    Vikhanskaya F, Erba E, D'Incalci M, Broggini M.
    Exp Cell Res; 1996 Sep 15; 227(2):380-5. PubMed ID: 8831577
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A p21(waf1)-independent pathway for inhibitory phosphorylation of cyclin-dependent kinase p34(cdc2) and concomitant G(2)/M arrest by the chemopreventive flavonoid apigenin.
    McVean M, Weinberg WC, Pelling JC.
    Mol Carcinog; 2002 Jan 15; 33(1):36-43. PubMed ID: 11807956
    [Abstract] [Full Text] [Related]

  • 16. Combretastatin-A4 prodrug induces mitotic catastrophe in chronic lymphocytic leukemia cell line independent of caspase activation and poly(ADP-ribose) polymerase cleavage.
    Nabha SM, Mohammad RM, Dandashi MH, Coupaye-Gerard B, Aboukameel A, Pettit GR, Al-Katib AM.
    Clin Cancer Res; 2002 Aug 15; 8(8):2735-41. PubMed ID: 12171907
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. p53 regulates a G2 checkpoint through cyclin B1.
    Innocente SA, Abrahamson JL, Cogswell JP, Lee JM.
    Proc Natl Acad Sci U S A; 1999 Mar 02; 96(5):2147-52. PubMed ID: 10051609
    [Abstract] [Full Text] [Related]

  • 20. Elevated cyclin G2 expression intersects with DNA damage checkpoint signaling and is required for a potent G2/M checkpoint arrest response to doxorubicin.
    Zimmermann M, Arachchige-Don AS, Donaldson MS, Dallapiazza RF, Cowan CE, Horne MC.
    J Biol Chem; 2012 Jun 29; 287(27):22838-53. PubMed ID: 22589537
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.